microRNA expression profiles as decision-making biomarkers in the management of bladder cancer

Keyphrases

• Bladder Cancer 100%
• Bladder Cancer Diagnosis 50%
• Cancer Patients 25%
• Chemoresistance 50%
• Clinical Outcomes 25%
• Clinical Prognosis 25%
• Disease Prognosis 25%
• Disease Progression 25%
• Disease Risk 25%
• Disease Stage 25%
• Diseases Therapeutic 25%
• High Risk 25%
• Malignant Potential 25%
• MicroRNA 75%
• MicroRNA Profile 100%
• MicroRNA Regulation 25%
• MicroRNA-34a (miR-34a) 25%
• MiR-100 25%
• MiR-146b 25%
• MiR-193a-3p 25%
• MiR-9 25%
• MiRNA Expression Profile 25%
• Muscle-invasive 100%
• Muscle-invasive Bladder Cancer 25%
• Neoadjuvant Chemotherapy 100%
• Neoadjuvant Chemotherapy Response 25%
• Non-muscle Invasive Bladder Cancer (NMIBC) 25%
• Poor Response 25%
• Profile Changes 25%
• Radical Cystectomy 50%
• Resistance to Chemotherapy 25%
• Therapeutic Response 50%
• Treatment Protocol 25%
• Tumor Diagnosis 25%
• Tumorigenesis 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Biological Marker 100%
• Bladder Cancer 100%
• Carcinogenesis 14%
• Chemotherapy 85%
• Disease Exacerbation 14%
• Diseases 14%
• Drug Resistance 28%
• Malignant Neoplasm 14%
• microRNA 100%
• microRNA 100 14%
• microRNA 9 14%
• Muscle Invasive Bladder Cancer 14%
• Neoplasm 14%
• Non Muscle Invasive Bladder Cancer 14%

Biochemistry, Genetics and Molecular Biology

• Carcinogenesis 33%
• Decision Making 100%
• Drug Resistance 66%
• MicroRNA 100%